^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    BioNTech

    i
    Other names: BioNTech | BioNTech AG | BioNTech SE | Neon Therapeutics | Neon Therapeutics, Inc. | BioNTech US Inc. | BioNTech US Inc | BioNTech US | BioNTech Diagnostics GmbH | BioNTech Diagnostics | Neon Therapeutics Inc | Neon Therapeutics Inc. | Neon Therapeutics, Inc | Biopharmaceutical New Technologies (BioNTech)
    Related tests:
    Evidence

    News

    3ms
    Tempus Announces Real World Data Collaboration with BioNTech (Tempus Press Release)
    "Tempus AI...today announced a multi-year collaboration with BioNTech SE... This collaboration leverages Tempus’ robust multimodal datasets in support of BioNTech’s next-generation oncolo- gy pipeline."
    Real-world evidence • Licensing / partnership
    1year
    Cerca Biotech announces ISO 13485:2016 certification (EIN Presswire)
    "Cerca Biotech...announced that its quality management system (QMS) has achieved ISO 13485:2016 certification for the design and development, production and distribution of in vitro diagnostics and software for molecular testing."
    Regulatory
    3years
    Cerca Biotech acquires MammaTyper® for molecular classification of breast cancer (EIN Presswire)
    "Cerca Biotech GmbH...announced an asset purchase agreement with BioNTech Diagnostics AG...relating to MammaTyper®, a molecular diagnostics for breast cancer subtyping. Under the agreement, Cerca will acquire from BioNTech its rights and interest in MammaTyper® and the associated nucleic acid extraction kit RNXtract®. Cerca will be responsible for the development and commercialization of the products worldwide."
    Licensing / partnership
    |
    MammaTyper® Kit